Treatment the pediatric rhinitis by CD(Cyclodextrin) garlic suspension

Authors

  • Yun Son An Lecturer, Department of ENT, Pyongyang University of Medical Sciences, DPR Korea.
  • Hyang Song O Chief Officer, Ministry of Public Health, DPR Korea
  • In Gyo So Doctor, Department of ENT, Pyongyang General Hospital, DPR Korea
  • Kwang Sam Pak Doctor, Department of ENT, Pyongyang General Hospital, DPR Korea

DOI:

https://doi.org/10.37591/rrjom.v12i2.2807

Abstract

Objective: The goal of this study was to identify the effectiveness of vasoconstriction, anti-inflammation and antibiosis of CD garlic powder and to apply this to the treatment of pediatric rhinitis. Materials and Methods: Experimental study objects: Materials: CD garlic powder: we used the CD garlic powder made at Pyongyang Taeun Pharmaceutical Factory. Strain: Escherichia coli O111(ATCC No.25922), Staphylococcus aureus 209-P(ATCC No.25923) purchased from National Microbiological Institute (Pyongyang, DPR Korea). Media: Peptone broth medium, Agar medium. Experimental animals. Toad (20-25g), Spragues-Dawley rats(120-180g), Rabbits(over 1.5Kg) These animals were selected without distinction of sex. (Purchased from the experimental animal shed at Pyongyang University of medical sciences). Clinical study objects: We selected 110 pediatric patients less than 14 years old with chronic rhinitis, who have no complications and no serious deviation of nasal septum. Result: CD garlic powder has less irritation and has remarkable actions of anti-inflammation, antibiosis and vasoconstriction. The treatment effect of CD garlic suspension was 87.5% when it was swabbed nasal cavity mucosa.

References

Onuora Chidinma et al., Therapeutic Effects of Garlic-A Review, Scientific Journal of Biology & Life Sciences,1(1): 2019 1~5.

Colín González AL, Santana RA, Silva Islas CA, Chánez Cárdenas ME, Santamaría A (2012) The antioxidant mechanisms underlying the aged garlic extract and S allylcysteine-induced protection, Oxidative Medicine and Cellular Longevity 10: 1155.

Aviello G, Abenavoli L, Borrelli F, Capasso R, Izzo AA, et al. (2009) Garlic: empiricism or science? Nat Prod Commun 4(12): 1785-1796.

Tsao SM, Yin MC (2001) In vitro antimicrobial activity of four diallyl sulphides occurring naturally in garlic and Chinese leek oil. J Med Microbiol 50(7): 646-649.

Nervi C (2006) Garlic Biochemistry: Effect on human health, Università degli Studi di Torino. Nutrition and Food Research 51(11): 1386-1397.

Nantz MP, Rowe CA, Muller CE, Creasy RA, Stanilka JM, et al. (2012) Supplementation with aged garlic extract improves both NK and γδ-T cell function and reduces the severity of cold and flu symptoms: a randomized double-blind placebo-controlled nutrition intervention. Clin Nutr 31 (3): 337-344.

Tariq Abdullah et al., A Strategic Call to Utilize EchinaceaGarlic in Flu-Cold Seasons Journal of The National Medical Association, Vol. 92, No. 1, January 2000, 48-51

Mehrbod, P. et al., Assessment of direct immunofluorescence assay in detection of antiviral effect of garlic extract on influenza virus, African Journal of Microbiology Research, Vol. 7(21), pp. 2608-2612, 21 May, 2013.

Josling P., Preventing the common cold with a garlic supplement: a double-blind placebo-controlled survey. Adv Ther 18(4) ,2001: 189-193.

Hahn G., Garlic: the science and therapeutic application of Allium sativum L and related species (2nd edn). Baltimore Williams and Wilkins, 1996, pp. 1-24.

Allen DB. et al. No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year. Allergy Asthma Proc. 2002; 23; 407~413.

G.K.Scadding et al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis(Revised Edition 2017; First edition 2007), Clin Exp Allergy. 2017; 47;856~889.

Meltzer EO et al. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis. Am J Rhinol Allergy. 2013; 27; 102~108.

F. Musshoff, Naphazoline intoxication in a child—a clinical and forensic toxicological case, Forensic Science International 134 (2003) 234–237.

Downloads

Published

2022-08-24

Issue

Vol. 12 No. 2 (2022)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.